{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-026867","form_type":"8-K","ticker":"SHPH","cik":"0001757499","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.891488+00:00","generated_at":"2026-05-17T07:40:18.445681+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Adam Chambers appointed to board of Shuttle Pharmaceuticals; principal of Bowery Consulting","bullets":["Appointment effective September 8, 2025; no family relationships with other directors/officers.","Chambers is principal of Bowery Consulting, lender under revolving loan (Feb 28, 2025) and consulting services (Mar 21, 2025).","No other material interests in transactions required to be disclosed under Item 404(a).","No arrangements or understandings under which he was appointed."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-026867","json":"https://secwatch.observer/filing/0001641172-25-026867.json","markdown":"https://secwatch.observer/filing/0001641172-25-026867.md","text":"https://secwatch.observer/filing/0001641172-25-026867.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757499/000164117225026867/0001641172-25-026867-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757499/000164117225026867/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:40:18.445681+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}